Susquehanna International Group
INBX

Susquehanna International Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Susquehanna International Group’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-63,710
Closed -$2.23M – 13636
2024
Q1 		$2.23M Sell
63,710
-42,485
-40% -$1.55M ﹤0.01% 5070
2023
Q4 		$4.04M Buy
106,195
+77,242
+267% +$1.66M ﹤0.01% 4084
2023
Q3 		$531K Buy
28,953
+3,304
+13% +$69.1K ﹤0.01% 8078
2023
Q2 		$666K Sell
25,649
-45,487
-64% -$1.06M ﹤0.01% 7639
2023
Q1 		$1.34M Buy
71,136
+55,262
+348% +$1.29M ﹤0.01% 6079
2022
Q4 		$391K Sell
15,874
-29,093
-65% -$855K ﹤0.01% 8438
2022
Q3 		$807K Buy
44,967
+13,810
+44% +$249K ﹤0.01% 7194
2022
Q2 		$354K Sell
31,157
-992
-3% -$14.6K ﹤0.01% 9118
2022
Q1 		$716K Sell
32,149
-12,647
-28% -$323K ﹤0.01% 8022
2021
Q4 		$1.96M Buy
+44,796
New +$1.79M ﹤0.01% 5560

Other funds holding INBX

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group's INBX Position: Q2 2024 in Review

Susquehanna International Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 63,710 shares — an estimated $2.23M sold.

Susquehanna International Group first reported a position in INBX in Q4 2021 and held it in 10 quarters. The position peaked at $4.04M in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

  • Susquehanna International Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 63,710 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $2.23M.
  • Susquehanna International Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Susquehanna International Group's Inhibrx, Inc. Common Stock position peaked at $4.04M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.